Launch and Postlaunch Price Developments of New Drugs in the US, Germany, and Switzerland

This cohort study examines launch and postlaunch price developments of new cancer drugs in the US, Germany, and Switzerland.

from JAMA Health Forum New Online https://ift.tt/Vp1OwMa